-
Stock Runners: eBay Inc. (NASDAQ:EBAY), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Tesla Motors Inc (NASDAQ:TSLA), NeuroMetrix Inc. (NASDAQ:NURO), Carmike Cinemas Inc. (NASDAQ:CKEC)
On Friday shares of eBay Inc. (NASDAQ:EBAY) closed at $59.41. Company’s sales growth for last 5 years was 15.50% and EPS growth for next 5 years is recorded as 10.49%. eBay Inc. (NASDAQ:EBAY), which is in the process of separating eBay and PayPal to create two independent publicly traded companies, has announced the directors who…
-
Stock Runners: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Range Resources Corporation (NYSE:RRC), New York REIT (NYSE:NYRT), Denbury Resources Inc. (NYSE:DNR), Ultragenyx Pharmaceutical (NASDAQ:RARE)
On Friday shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) closed at $6.39. Zacks downgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP) from a hold rating to a sell rating in a report issued on Wednesday. Range Resources Corporation (NYSE:RRC) in last trading activity moved up 5.74% to close at $64.29. Company weekly performance is -0.71% while its quarterly…
-
Hot News: Williams Companies (NYSE:WMB), MannKind Corp. (NASDAQ:MNKD), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Apollo Global Management, LLC (NYSE:APO), Delta Air Lines (NYSE:DAL)
On Tuesday shares of Williams Companies, Inc. (NYSE:WMB) closed at $49.50. Company’s sales growth for last 5 years was 7.70% and EPS growth for next 5 years is recorded as 18.00%. On 29 April, Williams Companies Inc. (NYSE:WMB) reported first-quarter 2015 adjusted earnings from continuing operations of 16 cents per share. The segment posted adjusted…
-
Hot Stock List: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Neonode (NASDAQ:NEON), Equity Residential (NYSE:EQR), Genworth Financial (NYSE:GNW), Otter Tail Corporation (NASDAQ:OTTR)
On Tuesday shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) closed at $7.18. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), announced that the company participated in the Annual GTC Diabetes Summit, in the 8th Diabetes Drug Discovery & Development Conference, took place April 27-29, 2015 in Boston. Dr. Miriam Kidron, Oramed’s Chief Scientific Officer, presented a session titled “Early Clinical…
-
Worth Watching Stocks: Delta Air Lines (NYSE:DAL), Regeneron Pharmaceuticals (NASDAQ:REGN), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Cisco Systems (NASDAQ:CSCO), Noble Energy (NYSE:NBL)
On Tuesday shares of Delta Air Lines, Inc. (NYSE:DAL) closed at $43.08. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5 years is recorded as 19.88%. Delta Air Lines, Inc. (NYSE:DAL) President Ed Bastian said this week at the Association of Corporate Travel Executives Global Corporate Travel Conference in…
-
Market Movers: Clean Harbors (NYSE:CLH), DryShips (NASDAQ:DRYS), Avago Technologies Limited (NASDAQ:AVGO), bluebird bio (NASDAQ:BLUE), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP
Clean Harbors, Inc. (NYSE:CLH) announced Revenues for the fourth quarter were $845.0 million, compared with $879.4 million in the same period of 2013. Income from operations in the fourth quarter of 2014 was $57.5 million, compared with $58.9 million in the same period of 2013. On Wednesday shares of Clean Harbors, Inc. (NYSE:CLH) closed at…
-
Traders Should Watch: Verizon Communications Inc. (NYSE:VZ), Tallgrass Energy Partners, LP (NYSE:TEP), Arena Pharmaceuticals (NASDAQ:ARNA), Oramed Pharmaceuticals (NASDAQ:ORMP), Plum Creek Timber (NYSE:PCL)
On 18 February, Verizon Communications Inc. (NYSE:VZ) named John Stratton as head of its wireless and wireline operations, handing a big new portfolio to an executive who could one day be in the race to run the company. On Friday shares of Verizon Communications Inc. (NYSE:VZ) closed at $48.97. Company’s sales growth for last 5…
-
Top Stocks: Emerald Oil (NYSEMKT:EOX), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Quintiles Transnational Holdings Inc. (NYSE:Q), E2open (NASDAQ:EOPN), Viper Energy Partners (NASDAQ:VNOM)
On February 11, Emerald Oil, Inc. (NYSEMKT:EOX) announced that it has completed the sale of 24,553,571 shares of its common stock. All shares of common stock were sold to the public at an offering price of $1.12 per share. The resulting net proceeds to the Company, after deducting underwriting discounts, commissions and other expenses, were…
-
Biotech Big Losers: Achillion Pharmaceuticals (NASDAQ:ACHN), Can-Fite BioPharma (NYSEMKT:CANF), Calithera Biosciences (NASDAQ:CALA), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Codexis (NASDAQ:CDXS)
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the pricing of an underwritten public offering of 12 million shares of its common stock at a price to the public of $10.25 per share. All shares in the offering will be sold by Achillion. On Wednesday shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) closed at $10.87. Company’s EPS growth for…
-
Traders Alert: Sprint Corporation (NYSE:S), Netlist Inc. (NASDAQ:NLST), Data I/O Corp. (NASDAQ:DAIO), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Vanguard Natural Resources, LLC (NASDAQ:VNR)
On 2 February, Sprint [NYSE: S] launched its inaugural Smartphone Encore Challenge, in conjunction with Brightstar Corp. and HOBI International, as a call-to-action for students to find profitable and innovative ways to repurpose old smartphones or their components. The challenge will be facilitated by Net Impact, the leading nonprofit that empowers a new generation to…